Gene: EPC2
Official Full Name: enhancer of polycomb homolog 2provided by HGNC
Gene Summary: Involved in positive regulation of double-strand break repair via homologous recombination and regulation of cell cycle. Part of NuA4 histone acetyltransferase complex and nucleosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28306 | EPC2 Knockout cell line (HeLa) | Human | EPC2 | 1:3~1:6 | Negative | Online Inquiry |
KO28307 | EPC2 Knockout cell line (HCT 116) | Human | EPC2 | 1:2~1:4 | Negative | Online Inquiry |
KO28308 | EPC2 Knockout cell line (HEK293) | Human | EPC2 | 1:3~1:6 | Negative | Online Inquiry |
KO28309 | EPC2 Knockout cell line (A549) | Human | EPC2 | 1:3~1:4 | Negative | Online Inquiry |
EPC2 Gene Knockout Cell Lines are genetically engineered cellular models that have been specifically designed to elucidate the role of the EPC2 gene in biological processes. These cell lines are invaluable tools for researchers looking to study gene function, cellular signaling pathways, and the molecular mechanisms underlying various diseases.
Key to the function of EPC2 Gene Knockout Cell Lines is their ability to mimic the loss-of-function scenarios that occur in pathogenic conditions. By employing CRISPR-Cas9 technology, these cell lines have undergone precise gene editing, resulting in a complete knockout of the EPC2 gene. This alteration allows researchers to investigate the phenotypic consequences of EPC2 gene disruption, providing insights into its role in cellular homeostasis, proliferation, differentiation, and response to external stimuli.
The scientific importance of these cell lines extends to numerous applications in both fundamental research and clinical studies. They serve as robust models for cancer research, drug development, and the exploration of genetic diseases. By using these knockout cell lines, scientists can assess potential therapeutic targets, evaluate drug efficacy, and gain a deeper understanding of molecular pathways associated with various health disorders.
What sets EPC2 Gene Knockout Cell Lines apart from alternatives is their high specificity and reliability. The CRISPR-Cas9 method ensures precise editing with minimal off-target effects, which is crucial for obtaining accurate experimental results. Furthermore, they are readily available and extensively characterized, allowing for easy integration into existing research workflows.
For researchers and clinicians, the value of these cell lines is evident in their ability to accelerate discoveries and validate hypotheses while reducing the time and resources typically required for generating knockout models. Our company specializes in providing high-quality biological products, ensuring that EPC2 Gene Knockout Cell Lines are backed by rigorous quality control and extensive technical support, empowering researchers in their quest for groundbreaking insights.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.